HK1204923A1 - Composition for controlled ovarian stimulation - Google Patents

Composition for controlled ovarian stimulation

Info

Publication number
HK1204923A1
HK1204923A1 HK15105458.7A HK15105458A HK1204923A1 HK 1204923 A1 HK1204923 A1 HK 1204923A1 HK 15105458 A HK15105458 A HK 15105458A HK 1204923 A1 HK1204923 A1 HK 1204923A1
Authority
HK
Hong Kong
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
HK15105458.7A
Other languages
English (en)
Chinese (zh)
Inventor
Joan-Carles Arce
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1204923(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HK1204923A1 publication Critical patent/HK1204923A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK15105458.7A 2011-08-08 2014-11-17 Composition for controlled ovarian stimulation HK1204923A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08

Publications (1)

Publication Number Publication Date
HK1204923A1 true HK1204923A1 (en) 2015-12-11

Family

ID=46785372

Family Applications (2)

Application Number Title Priority Date Filing Date
HK14111597.8A HK1198005A1 (zh) 2011-08-08 2014-11-17 用於受控的卵巢刺激的組合物
HK15105458.7A HK1204923A1 (en) 2011-08-08 2014-11-17 Composition for controlled ovarian stimulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK14111597.8A HK1198005A1 (zh) 2011-08-08 2014-11-17 用於受控的卵巢刺激的組合物

Country Status (31)

Country Link
US (4) US9694052B2 (ko)
EP (9) EP4005588B1 (ko)
JP (5) JP6161609B2 (ko)
KR (7) KR20230024442A (ko)
CN (2) CN107281470A (ko)
AR (1) AR087476A1 (ko)
AU (3) AU2012293647B2 (ko)
BR (2) BR122020001644B1 (ko)
CA (1) CA2844282A1 (ko)
CY (1) CY1117214T1 (ko)
DK (8) DK3395357T3 (ko)
ES (7) ES2871405T3 (ko)
FI (2) FI3756681T3 (ko)
HK (2) HK1198005A1 (ko)
HR (8) HRP20230607T1 (ko)
HU (7) HUE027674T2 (ko)
IL (2) IL300380A (ko)
JO (1) JO3092B1 (ko)
LT (7) LT3646881T (ko)
MX (2) MX348981B (ko)
PL (8) PL3395357T3 (ko)
PT (6) PT4005588T (ko)
RS (8) RS59107B1 (ko)
RU (2) RU2613324C3 (ko)
SA (1) SA112330762B1 (ko)
SI (7) SI3195875T1 (ko)
SM (1) SMT201600038B (ko)
TR (2) TR201911269T4 (ko)
TW (2) TWI555530B (ko)
WO (1) WO2013020996A1 (ko)
ZA (2) ZA201400952B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP3237608B1 (en) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-dependent sialidase activity
JP7079094B2 (ja) * 2015-04-17 2022-06-01 フェリング ベスローテン フェンノートシャップ 不妊症の処置のための組成物
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
EA201890163A1 (ru) * 2015-09-17 2018-10-31 Гликотоп Гмбх Композиция фолликулостимулирующего гормона млекопитающего с повышенной стабильностью
MA46353A (fr) * 2016-09-30 2019-08-07 Myovant Sciences Gmbh Méthodes de traitement de l'infertilité féminine
ES2904787T3 (es) * 2017-09-01 2022-04-06 Ferring Bv Composición para la estimulación ovárica controlada
US20210038694A1 (en) * 2018-04-30 2021-02-11 Ferring B.V. Composition for controlled ovarian stimulation
KR20210079276A (ko) 2018-10-17 2021-06-29 훼링 비.브이. 제어된 난소 자극을 위한 조성물 및 방법
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗***中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
WO2023186331A1 (en) 2022-04-01 2023-10-05 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
RS32804A (en) * 2001-10-22 2007-02-05 Applied Research Systems Ars Holding N.V., Gonadotrophins for folliculogenesis
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
WO2012042381A1 (en) * 2010-09-29 2012-04-05 Ferring B.V. Composition for controlled ovarian stimulation
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
JP2020147600A (ja) 2020-09-17
RS54561B1 (en) 2016-06-30
KR20200121918A (ko) 2020-10-26
PL3195875T3 (pl) 2019-01-31
KR20210099162A (ko) 2021-08-11
HRP20191437T1 (hr) 2019-11-15
CA2844282A1 (en) 2013-02-14
HUE054312T2 (hu) 2021-08-30
EP3566712A1 (en) 2019-11-13
MX348981B (es) 2017-07-06
JP2023134561A (ja) 2023-09-27
IL300380A (en) 2023-04-01
EP4306174A2 (en) 2024-01-17
RS61672B1 (sr) 2021-04-29
ES2704878T3 (es) 2019-03-20
RU2017106756A3 (ko) 2020-07-09
HRP20210722T1 (hr) 2021-06-11
ES2950911T3 (es) 2023-10-16
PL3756681T3 (pl) 2023-08-21
SI3395357T1 (sl) 2019-09-30
MX2014001489A (es) 2014-04-25
RU2017106756A (ru) 2019-01-23
PT3395357T (pt) 2019-08-27
RS58198B1 (sr) 2019-03-29
CN107281470A (zh) 2017-10-24
WO2013020996A1 (en) 2013-02-14
RS57897B1 (sr) 2019-01-31
PL2741763T3 (pl) 2016-07-29
SI3646881T1 (sl) 2021-08-31
SI3756681T1 (sl) 2023-08-31
HUE062640T2 (hu) 2023-11-28
EP3395357B1 (en) 2019-05-15
MX2020010991A (es) 2020-11-09
ES2884947T3 (es) 2021-12-13
IL230696A0 (en) 2014-03-31
DK3566712T3 (da) 2021-04-19
IL230696B2 (en) 2023-07-01
RU2613324C3 (ru) 2021-06-09
RU2739037C2 (ru) 2020-12-21
ES2742163T3 (es) 2020-02-13
DK4005588T3 (da) 2024-04-29
ES2692774T3 (es) 2018-12-05
TW201309322A (zh) 2013-03-01
US20180028620A1 (en) 2018-02-01
RU2014102924A (ru) 2015-09-20
HRP20240420T1 (hr) 2024-06-21
DK2821080T3 (en) 2019-01-28
EP3756681B1 (en) 2023-05-03
JP2019077693A (ja) 2019-05-23
ZA201400952B (en) 2022-03-30
EP3756681A1 (en) 2020-12-30
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
PT2821080T (pt) 2018-12-17
EP4005588A1 (en) 2022-06-01
HRP20210277T1 (hr) 2021-04-02
TR201900071T4 (tr) 2019-01-21
PL3566712T3 (pl) 2021-07-12
RS65485B1 (sr) 2024-05-31
EP2821080A1 (en) 2015-01-07
IL230696B1 (en) 2023-03-01
BR112014002884A2 (pt) 2017-02-21
ZA201506382B (en) 2017-01-25
KR20230024442A (ko) 2023-02-20
TW201716082A (zh) 2017-05-16
DK3195875T3 (en) 2018-11-12
KR20140054191A (ko) 2014-05-08
JP2017141253A (ja) 2017-08-17
RS61843B1 (sr) 2021-06-30
BR122020001644B1 (pt) 2022-08-02
PT3756681T (pt) 2023-07-25
SI2821080T1 (sl) 2019-01-31
KR102499969B1 (ko) 2023-02-14
PT3195875T (pt) 2018-10-31
EP3566712B1 (en) 2021-01-27
HUE041769T2 (hu) 2019-05-28
RU2613324C2 (ru) 2017-03-15
PL3395357T3 (pl) 2019-11-29
SA112330762B1 (ar) 2015-10-08
EP3646881A1 (en) 2020-05-06
AU2018203222A1 (en) 2018-05-24
AU2016273925B2 (en) 2018-03-15
KR102353144B1 (ko) 2022-01-18
FI3756681T3 (fi) 2023-07-28
RS64328B1 (sr) 2023-08-31
LT3566712T (lt) 2021-03-10
HRP20181639T1 (hr) 2018-12-14
EP3395357A1 (en) 2018-10-31
SMT201600038B (it) 2016-02-25
HRP20160145T1 (hr) 2016-04-08
EP3646881B1 (en) 2021-04-28
EP4005588B1 (en) 2024-02-07
HRP20190023T1 (hr) 2019-02-22
EP4306174A3 (en) 2024-04-10
HUE027674T2 (en) 2016-11-28
LT3756681T (lt) 2023-07-25
AU2012293647B2 (en) 2016-10-06
AU2018203222B2 (en) 2020-03-12
JP6500050B2 (ja) 2019-04-10
HK1198005A1 (zh) 2015-03-06
LT3646881T (lt) 2021-05-25
DK2741763T3 (da) 2016-02-15
KR20210143934A (ko) 2021-11-29
TWI555530B (zh) 2016-11-01
JP6718951B2 (ja) 2020-07-08
LT3195875T (lt) 2018-11-12
KR20190140098A (ko) 2019-12-18
NZ620369A (en) 2015-12-24
EP3195875B1 (en) 2018-07-25
PL4005588T3 (pl) 2024-06-10
EP2741763B1 (en) 2015-11-18
JP6161609B2 (ja) 2017-07-12
TR201911269T4 (tr) 2019-08-21
RU2739037C3 (ru) 2021-09-08
PT3646881T (pt) 2021-06-02
EP3195875A1 (en) 2017-07-26
HUE053716T2 (hu) 2021-07-28
ES2562648T3 (es) 2016-03-07
DK3646881T3 (da) 2021-07-26
US9694052B2 (en) 2017-07-04
LT3395357T (lt) 2019-08-26
AU2012293647A1 (en) 2014-02-27
CY1117214T1 (el) 2017-04-05
KR102014469B1 (ko) 2019-08-26
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
SI3566712T1 (sl) 2021-04-30
PL3646881T3 (pl) 2021-11-02
HRP20230607T1 (hr) 2023-09-29
US10624953B2 (en) 2020-04-21
RS59107B1 (sr) 2019-09-30
SI2741763T1 (sl) 2016-02-29
AU2016273925A1 (en) 2017-01-12
FI4005588T3 (fi) 2024-05-15
JP7309660B2 (ja) 2023-07-18
DK3756681T3 (da) 2023-07-31
US20200345814A1 (en) 2020-11-05
ES2871405T3 (es) 2021-10-28
JP2014522871A (ja) 2014-09-08
TWI657822B (zh) 2019-05-01
CN103732243A (zh) 2014-04-16
HUE044610T2 (hu) 2019-11-28
AR087476A1 (es) 2014-03-26
PL2821080T3 (pl) 2019-04-30
DK3395357T3 (da) 2019-08-19
KR20190100449A (ko) 2019-08-28
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
LT2821080T (lt) 2019-01-10
JO3092B1 (ar) 2017-03-15
HUE040058T2 (hu) 2019-02-28
KR102111514B1 (ko) 2020-05-18
US20220370567A1 (en) 2022-11-24
US20140329748A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika